{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:22:14Z","timestamp":1778001734529,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11255-018-2012-9","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T03:18:10Z","timestamp":1539573490000},"page":"2131-2137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of ABO blood groups and blood-based biomarkers as a predictor of growth kinetics of renal angiomyolipoma"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6629-5153","authenticated-orcid":false,"given":"Burak","family":"Arslan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okan","family":"G\u00fcrkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bugra","family":"\u00c7etin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6yk\u00fc Aksoy","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha","family":"G\u00f6v","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6khan","family":"Yaz\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tolga","family":"Eroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa As\u0131m","family":"Avc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enver","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"issue":"3","key":"2012_CR1","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.juro.2008.05.041","volume":"180","author":"BR Lane","year":"2008","unstructured":"Lane BR, Aydin H, Danforth TL, Zhou M, Remer EM, Novick AC et al (2008) Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol 180(3):836\u2013843","journal-title":"J Urol"},{"issue":"5","key":"2012_CR2","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00261-014-0129-6","volume":"39","author":"A Fittschen","year":"2014","unstructured":"Fittschen A, Wendlik I, Oeztuerk S, Kratzer W, Akinli AS, Haenle MM et al (2014) Prevalence of sporadic renal angiomyolipoma: a retrospective analysis of 61,389 in- and out-patients. Abdom Imaging 39(5):1009\u20131013","journal-title":"Abdom Imaging"},{"issue":"5","key":"2012_CR3","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3349\/ymj.2010.51.5.728","volume":"51","author":"KC Koo","year":"2010","unstructured":"Koo KC, Kim WT, Ham WS, Lee JS, Ju HJ, Choi YD (2010) Trends of presentation and clinical outcome of treated renal angiomyolipoma. Yonsei Med J 51(5):728\u2013734","journal-title":"Yonsei Med J"},{"issue":"4 Pt1","key":"2012_CR4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.juro.2015.07.126","volume":"195","author":"AS Flum","year":"2016","unstructured":"Flum AS, Hamoui N, Said MA, Yang XJ, Casalino DD, McGuire BB et al (2016) Update on the diagnosis and management of renal angiomyolipoma. J Urol 195(4 Pt1):834\u2013846","journal-title":"J Urol"},{"issue":"1","key":"2012_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.eururo.2016.01.048","volume":"70","author":"JR Bhatt","year":"2016","unstructured":"Bhatt JR, Richard PO, Kim NS, Finelli A, Manickavachagam K, Legere L et al (2016) Natural history of renal angiomyolipoma (AML): most patients with large AMLs> 4 cm can be offered active surveillance as an initial management strategy. Eur Urol 70(1):85\u201390","journal-title":"Eur Urol"},{"issue":"11","key":"2012_CR6","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1089\/end.2010.0223","volume":"24","author":"AC Mues","year":"2010","unstructured":"Mues AC, Palacios JM, Haramis G, Casazza C, Badani K, Gupta M et al (2010) Contemporary experience in the management of angiomyolipoma. J Endourol 24(11):1883\u20131886","journal-title":"J Endourol"},{"issue":"2","key":"2012_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.tmrv.2011.08.002","volume":"26","author":"F Yamamoto","year":"2012","unstructured":"Yamamoto F, Cid E, Yamamoto M, Blancher A (2012) ABO research in the modern era of genomics. Transfus Med Rev 26(2):103\u2013118","journal-title":"Transfus Med Rev"},{"issue":"10","key":"2012_CR8","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1046\/j.1537-2995.1998.381098440863.x","volume":"38","author":"T Eastlund","year":"1998","unstructured":"Eastlund T (1998) The histo-blood group ABO system and tissue transplantation. Transfusion 38(10):975\u2013988","journal-title":"Transfusion"},{"issue":"2","key":"2012_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s11239-013-1027-4","volume":"38","author":"GM Liumbruno","year":"2014","unstructured":"Liumbruno GM, Franchini M (2014) Hemostasis, cancer, and ABO blood group: the most recent evidence of association. J Thromb Thrombolysis 38(2):160\u2013166","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"2012_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.clgc.2016.04.008","volume":"14","author":"M Marchioni","year":"2016","unstructured":"Marchioni M, Primiceri G, Ingrosso M, Filograna R, Castellan P, De Francesco P et al (2016) The clinical use of the Neutrophil to lymphocyte ratio in urothelial cancer: a systematic review. Clin Genitourin Cancer 14(6):473\u2013484","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"2012_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/bju.13545","volume":"119","author":"H Lee","year":"2017","unstructured":"Lee H, Lee SE, Byun SS, Kim HH, Kwak C, Hong SK (2017) De Ritis ratio (aspartate transaminase\/alanine transaminase ratio) as a signifcant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study. BJU Int 119(2):261\u2013267","journal-title":"BJU Int"},{"issue":"5","key":"2012_CR12","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","volume":"67","author":"B Ljungberg","year":"2014","unstructured":"Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M et al (2014) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913\u2013924","journal-title":"Eur Urol"},{"issue":"3","key":"2012_CR13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/bju.12604","volume":"114","author":"I Ouzaid","year":"2014","unstructured":"Ouzaid I, Autorino R, Fatica R, Herts BR, McLennan G, Remer EM (2014) Active surveillance for renal angiomyolipoma: outcomes and factors predictive of delayed intervention. BJU Int 114(3):412\u2013417","journal-title":"BJU Int"},{"issue":"3","key":"2012_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.diii.2015.12.004","volume":"97","author":"J Champagnac","year":"2016","unstructured":"Champagnac J, Melodelima C, Martinelli T, Pagnoux G, Badet L, Juilard L et al (2016) Microaneurysms in renal angiomyolipomas: can clinical and computed tomography features predict their presence and size? Diagn Interv Imaging 97(3):321\u2013326","journal-title":"Diagn Interv Imaging"},{"issue":"6","key":"2012_CR15","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.canep.2012.07.001","volume":"36","author":"HK Joh","year":"2012","unstructured":"Joh HK, Cho E, Choueiri TK (2012) ABO blood group and risk of renal cell cancer. Cancer Epidemiol 36(6):528\u2013532","journal-title":"Cancer Epidemiol"},{"issue":"5b","key":"2012_CR16","doi-asserted-by":"publisher","first-page":"E62","DOI":"10.1111\/bju.12436","volume":"113","author":"M Martino De","year":"2014","unstructured":"De Martino M, Waldert M, Haitel A, Schatzl G, Shariat SF, Klatte T (2014) Evaluation of ABO blood group as a prognostic marker in renal cell carcinoma (RCC). BJU Int 113(5b):E62\u2013E66","journal-title":"BJU Int"},{"issue":"11 Pt B","key":"2012_CR17","doi-asserted-by":"publisher","first-page":"E641","DOI":"10.1111\/j.1464-410X.2012.11366.x","volume":"110","author":"SD Kaffenberger","year":"2012","unstructured":"Kaffenberger SD, Morgan TM, Stratton KL, Boachie AM, Barocas DA, Chang SS et al (2012) ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma. BJU Int 110(11 Pt B):E641\u2013E646","journal-title":"BJU Int"},{"issue":"4","key":"2012_CR18","first-page":"2765","volume":"13","author":"K Ko","year":"2016","unstructured":"Ko K, Park YH, Jeong CW, Ku JH, Kim HH, Kwak C (2016) Prognostic significance of blood type A in patients with renal cell carcinoma. Urol J 13(4):2765\u20132772","journal-title":"Urol J"},{"issue":"8","key":"2012_CR19","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.ejso.2017.03.006","volume":"43","author":"C Paterson","year":"2017","unstructured":"Paterson C, Yew-Fung C, Sweeney C, Szewczyk-Bieda M, Lnag S, Nabi G (2017) Predictors of growth kinetics and outcomes in small renal masses (SRM \u2264 4 cm in size): tayside Active Surveillance Cohort (TASC) Study. Eur J Surg Oncol 43(8):1589\u20131597","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"2012_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0304-4165(99)00183-X","volume":"1473","author":"S Hakomori","year":"1999","unstructured":"Hakomori S (1999) Antigen structure and genetic basis of histo-blood groups A, B and 0: their changes associated with human cancer. Biochim Biophys Acta 1473(1):247\u2013266","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"2012_CR21","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.4049\/jimmunol.164.9.4868","volume":"164","author":"MM Halloran","year":"2000","unstructured":"Halloran MM, Carley WW, Polverini PJ, Haskell CJ, Phan S, Anderson BJ et al (2000) Ley\/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. J Immunol 164(9):4868\u20134877","journal-title":"J Immunol"},{"issue":"3","key":"2012_CR22","first-page":"117","volume":"34","author":"M Botros","year":"2013","unstructured":"Botros M, Sikaris KA (2013) The De Ritis ratio: the test of time. Clin Biochem Rev 34(3):117\u2013130","journal-title":"Clin Biochem Rev"},{"issue":"5","key":"2012_CR23","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.clgc.2017.04.011","volume":"15","author":"H Ishihara","year":"2017","unstructured":"Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J et al (2017) Evaluation of preoperative aspartate transaminase\/alanine transaminase ratio as an independent predictive biomarker in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy: a propensity score matching study. Clin Genitourin Cancer 15(5):598\u2013604","journal-title":"Clin Genitourin Cancer"},{"issue":"5930","key":"2012_CR24","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029\u20131033","journal-title":"Science"},{"issue":"4","key":"2012_CR25","first-page":"1392","volume":"36","author":"WV Greenhouse","year":"1976","unstructured":"Greenhouse WV, Lehninger AL (1976) Ocurrence of the malate-aspartate shuttle in various tumor types. Cancer Res 36(4):1392\u20131396","journal-title":"Cancer Res"},{"issue":"8","key":"2012_CR26","first-page":"9446","volume":"8","author":"W Li","year":"2015","unstructured":"Li W, Guo L, Bi X, Ma J, Zheng S (2015) Immunohistochemistry of p53 and Ki-67 and p53 mutation analysis in renal epithelioid angiomyolipoma. Int J Clin Exp Pathol 8(8):9446\u20139451","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"2012_CR27","doi-asserted-by":"publisher","first-page":"e0199371","DOI":"10.1371\/journal.pone.0199371","volume":"13","author":"F Bertolini","year":"2018","unstructured":"Bertolini F, Casarotti G, Righi L, Bollito E, Albera C, Racca SA et al (2018) Human renal angiomyolipoma cells of male and female origin can migrate and are influenced by microenviromental factors. PLoS ONE 13(6):e0199371","journal-title":"PLoS ONE"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-018-2012-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-2012-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-2012-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T10:03:37Z","timestamp":1720692217000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-018-2012-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2012"],"URL":"https:\/\/doi.org\/10.1007\/s11255-018-2012-9","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"assertion":[{"value":"23 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}